Biopharmaceutical price gouging has long enraged politicians and patients alike — mounting pressure on drugmakers to not appear like they put profit before patients — which has led to a slowing in size and frequency of price hikes, a Leerink analysis has found.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,